| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Clin Rheumatol] 2021 Dec; Vol. 40 (12), pp. 5009-5017. <i>Date of Electronic Publication: </i>2021 Jul 19.
- MeSH Terms: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / diagnosis ; Glomerulonephritis* / epidemiology ; Antibodies, Antineutrophil Cytoplasmic ; China / epidemiology ; Humans ; Retrospective Studies ; Risk Factors
- References: Geetha D, Jefferson JA (2020) ANCA-Associated Vasculitis: Core Curriculum 2020. Am J Kidney Dis 75(1):124–137. (PMID: 10.1053/j.ajkd.2019.04.031) ; Haroun MK, Stone JH, Nair R, Racusen L, Hellmann DB, Eustace JA (2002) Correlation of percentage of normal glomeruli with renal outcome in Wegener's granulomatosis. Am J Nephrol 22(5-6):497–503. (PMID: 10.1159/000065283) ; Bajema IM, Hagen EC, Hermans J, Noël LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA, for the EC/BCR Project for ANCA-Assay Standardisation (1999) Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56(5):1751–1758. (PMID: 10.1046/j.1523-1755.1999.00758.x) ; de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N et al (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol : JASN 17(8):2264–2274. (PMID: 10.1681/ASN.2005080870) ; Neumann I, Kain R, Regele H, Soleiman A, Kandutsch S, Meisl FT (2005) Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant 20(1):96–104. (PMID: 10.1093/ndt/gfh563) ; Tanna A, Guarino L, Tam FW, Rodriquez-Cubillo B, Levy JB, Cairns TD et al (2015) Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transplant 30(7):1185–1192. (PMID: 10.1093/ndt/gfu237) ; Ellis CL, Manno RL, Havill JP, Racusen LC, Geetha D (2013) Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome. BMC Nephrol 14:210. (PMID: 10.1186/1471-2369-14-210) ; Muso E, Endo T, Itabashi M, Kakita H, Iwasaki Y, Tateishi Y, Komiya T, Ihara T, Yumura W, Sugiyama T, Joh K, Suzuki K (2013) Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts. Clin Exp Nephrol 17(5):659–662. (PMID: 10.1007/s10157-012-0755-7) ; Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, Noël LH, Pusey CD, Waldherr R, Bruijn JA, Bajema IM (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol : JASN 21(10):1628–1636. (PMID: 10.1681/ASN.2010050477) ; Iwakiri T, Fujimoto S, Kitagawa K, Furuichi K, Yamahana J, Matsuura Y, Yamashita A, Uezono S, Shimao Y, Hisanaga S, Tokura T, Wada T, Kitamura K, Asada Y (2013) Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. BMC Nephrol 14:125. (PMID: 10.1186/1471-2369-14-125) ; Quintana LF, Perez NS, De Sousa E, Rodas LM, Griffiths MH, Sole M et al (2014) ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis.Nephrol Dial Transplant 29(9):1764–1769. (PMID: 10.1093/ndt/gfu084) ; Lee T, Gasim A, Derebail VK, Chung Y, McGregor JG, Lionaki S et al (2014) Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure. Clin J Am Soc Nephrol : CJASN 9(5):905–913. (PMID: 10.2215/CJN.08290813) ; Huang S, Shen Q, Yang R, Lai H, Zhang J (2018) An evaluation of the 2010 histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a Bayesian network meta-analysis. Int Urol Nephrol 50(10):1853–1861. (PMID: 10.1007/s11255-018-1941-7) ; Brix SR, Noriega M, Tennstedt P, Vettorazzi E, Busch M, Nitschke M, Jabs WJ, Özcan F, Wendt R, Hausberg M, Sellin L, Panzer U, Huber TB, Waldherr R, Hopfer H, Stahl RAK, Wiech T (2018) Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney Int 94(6):1177–1188. (PMID: 10.1016/j.kint.2018.07.020) ; Hong Y, Shi P, Liu X, Yang L, Li K, Xu F, Liang S, Liu Z, Zhang H, Chen Y, Hu W (2019) Distinction between MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese patients: a retrospective single-center study. Clin Rheumatol 38(6):1665–1673. (PMID: 10.1007/s10067-019-04458-9) ; Pearce FA, Craven A, Merkel PA, Luqmani RA, Watts RA (2017) Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford, England) 56(11):1962–1969. (PMID: 10.1093/rheumatology/kex293) ; Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DGI, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11. (PMID: 10.1002/art.37715) ; Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612. (PMID: 10.7326/0003-4819-150-9-200905050-00006) ; Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, Flossmann O, Hall C, Hollywood J, Jayne D, Jones R, Lanyon P, Muir A, Scott D, Young L, Luqmani RA (2009) Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68(12):1827–1832. (PMID: 10.1136/ard.2008.101279) ; Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen TS, Papadimitriou JC, Randhawa PS, Rayner DC, Roberts I, Rose S, Rush D, Salinas-Madrigal L, Salomon DR, Sund S, Taskinen E, Trpkov K, Yamaguchi Y (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int 55(2):713–723. (PMID: 10.1046/j.1523-1755.1999.00299.x) ; Wallace ZS, Miloslavsky EM (2020) Management of ANCA associated vasculitis. BMJ (Clinical research ed) 368:m421. ; Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, Höglund P, Jayne D, Luqmani R, Mahr A, Mukhtyar C, Pusey C, Rasmussen N, Stegeman C, Walsh M, Westman K, for the European Vasculitis Study Group (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70(3):488–494. (PMID: 10.1136/ard.2010.137778) ; Villacorta J, Diaz-Crespo F, Guerrero C, Acevedo M, Cavero T, Fernandez-Juarez G (2021) Long-term validation of the renal risk score for vasculitis in a Southern European population. Clin Kidney J 14(1):220–225. (PMID: 10.1093/ckj/sfaa073) ; Ge Y, Yang G, Yu X, Sun B, Zhang B, Yuan Y, Zeng M, Wang N, Mao H, Xing C (2021) Outcome predictors of biopsy-proven myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Front Immunol 11:607261. (PMID: 10.3389/fimmu.2020.607261) ; Lim JH, Han MH, Kim YJ, Jeon Y, Jung HY, Choi JY, Cho JH, Kim CD, Kim YL, Lee H, Kim DK, Moon KC, Park SH (2021) Histopathologic and clinicopathologic classifications of antineutrophil cytoplasmic antibody-associated glomerulonephritis: a validation study in a Korean cohort. Kidney Res Clin Pract 40(1):77–88. (PMID: 10.23876/j.krcp.20.184) ; Gercik O, Bilgin E, Solmaz D, Cakalagaoglu F, Saglam A, Aybi O, Kardas RC, Soypacaci Z, Kabadayi G, Yildirim T, Kurut Aysin I, Karadag O, Akar S (2020) Histopathological subgrouping versus renal risk score for the prediction of end-stage renal disease in ANCA-associated vasculitis. Ann Rheum Dis 79(5):675–676. (PMID: 10.1136/annrheumdis-2019-216742) ; Wu T, Shen C, Zhong Y, Ooi JD, Zhou YO, Chen JB, Meng T, Xiao Z, Lin W, Ao X, Xiao X, Zhou Q, Xiao P (2021) Differences between myeloperoxidase-antineutrophil cytoplasmic autoantibody (ANCA) and proteinase 3-ANCA associated vasculitis: A retrospective study from a single center in China. Exp Ther Med 21(6):561. (PMID: 10.3892/etm.2021.9993)
- Grant Information: 81970628 National Natural Science Foundation of China; 20200201488JC Science and Technology Development Plan Project of Jilin province; 20190304042YY Science and Technology Development Plan Project of Jilin province; 2018J048 Jilin Province Sanitation and Health Technology
- Contributed Indexing: Keywords: ANCA-associated glomerulonephritis; Clinicopathological manifestation; Outcome; The renal risk score
- Substance Nomenclature: 0 (Antibodies, Antineutrophil Cytoplasmic)
- Entry Date(s): Date Created: 20210720 Date Completed: 20211119 Latest Revision: 20211119
- Update Code: 20231215
|
